therapeutics

Aurora Cannabis Expands Again in a 2.5 Billion Deal with MedReleaf

Aurora Cannabis Expands Again in a 2.5 Billion Deal with MedReleaf

Just months after  buying out CanniMed Therapeutics for C$1.23 billion ($1 billion U.S.D.)  making it the largest merger in Canada at the time, Aurora Cannabis Inc (TSE: ACB) announced on Monday that it will buy rival MedReleaf Corp (..

Juno Shares Surge on Celgene’s $9 Billion Acquisition

Juno Shares Surge on Celgene’s $9 Billion Acquisition

Juno Therapeutics Inc. (NASDAQ: JUNO) shares continued to surge on Monday after Celgene Corp. (NASDAQ: CELG) had entered into an agreement to acquire Juno for a total of $9 billion or $87 per share. Juno shares rose 27 percent during Monday&rsq..

Spark Therapeutics offers to cure blindness for $850,000

Spark Therapeutics offers to cure blindness for $850,000

Spark Therapeutics Inc (NASDAQ: ONCE) Luxturna, the first gene therapy in the U.S., has been approved by the Food and Drug Administration. The gene therapy is intended to treat a rare, inherited retinal disease that could possibly cause blindness. U..

Revance Therapeutics Shares Jumped After Positive Top-Line Results From Phase 3 Trial

Revance Therapeutics Shares Jumped After Positive Top-Line Results From Phase 3 Trial

Revance Therapeutics Inc (NASDAQ: RVNC) is a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions. On Tuesday shares of the Revance jumped about 10% a after the company announced its n..

Insys co-founder Arrested on alleged Nationwide Opioid Scheme

Insys co-founder Arrested on alleged Nationwide Opioid Scheme

Co-Founder of Insys Therapeutics Inc. (NASDAQ: INSY) was arrested on Thursday by federal agents and charged with bribery, racketeering, and fraud to cause the illegal distribution of Fentanyl.John Kapoor was taken into custody in Phoenix, Arizona. K..